
Please try another search
Microlin Bio, Inc., a development stage therapeutic company, focuses on developing and marketing microRNA therapies for the treatment of cancer. It intends to develop antimiR and miR replacement therapies to treat lung, ovarian, colorectal, and prostate cancers. The company was founded in 2013 and is headquartered New York, New York.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review